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The Induction of a Type 1 Immune Response following a
Trypanosoma brucei Infection Is MyD88 Dependent1
Michael B. Drennan,2*†‡ Benoıˆt Stijlemans,† Jan Van Den Abbeele,§ Valerie J. Quesniaux,‡
Mark Barkhuizen,* Frank Brombacher,* Patrick De Baetselier,† Bernhard Ryffel,*‡ and
Stefan Magez*†
The initial host response toward the extracellular parasite Trypanosoma brucei is characterized by the early release of inflam-
matory mediators associated with a type 1 immune response. In this study, we show that this inflammatory response is dependent
on activation of the innate immune system mediated by the adaptor molecule MyD88. In the present study, MyD88-deficient
macrophages are nonresponsive toward both soluble variant-specific surface glycoprotein (VSG), as well as membrane-bound
VSG purified from T. brucei. Infection of MyD88-deficient mice with either clonal or nonclonal stocks of T. brucei resulted in
elevated levels of parasitemia. This was accompanied by reduced plasma IFN- and TNF levels during the initial stage of infection,
followed by moderately lower VSG-specific IgG2a Ab titers during the chronic stages of infection. Analysis of several TLR-
deficient mice revealed a partial requirement for TLR9 in the production of IFN- and VSG-specific IgG2a Ab levels during T.
brucei infections. These results implicate the mammalian TLR family and MyD88 signaling in the innate immune recognition of
T. brucei. The Journal of Immunology, 2005, 175: 2501–2509.
I t is generally accepted that the triggering of an innate im-mune response is mediated by recognition of invading mi-croorganisms by pattern recognition receptors (PRRs)3
present on APCs (1, 2). Within the family of PRRs, a family of
evolutionarily conserved germline-encoded transmembrane recep-
tors called TLRs initiate intracellular signaling cascades upon ex-
posure to microbial molecules (3, 4). Distinct TLRs stimulate APC
function in response to a diversity of ligands, including LPS, bac-
terial flagellin, lipoteichoic acid, peptidoglycan, and nucleic acid
structures present on bacterial, fungal, and viral pathogens (2). In
general, the activation of individual TLRs by their corresponding
ligands is associated with the recruitment of an intracellular adap-
tor molecule, namely MyD88 (3). The production of inflammatory
cytokines associated with early-phase NF-B activation is associ-
ated with a MyD88-dependent innate immune response (4), al-
though TLR-dependent, MyD88-independent production of IFN-
and expression of IFN-inducible genes has been reported (5, 6). To
date, several reports have investigated the role of TLRs in initiat-
ing an innate immune response against experimental parasitic in-
fections, including Trypanosoma cruzi, Leishmania major, Plas-
modium berghei, and Toxoplasma gondii (7–12). Collectively, the
importance of MyD88-dependent signaling was established both in
vitro and in vivo. Using in vitro assays, APCs deficient in MyD88
displayed impaired IL-12 responses upon stimulation with parasite
Ags, whereas animals deficient in MyD88 were more susceptible
to live infections when compared with wild-type controls. In these
models, susceptibility toward a variety of parasitic infections was
associated with a decreased Th1 response, the induction of which
being associated with the MyD88-dependent activation of the in-
nate immune system.
The necessity to mount an early polarized variant-specific sur-
face glycoprotein (VSG) type 1 immune response following an
African trypanosome infection has been well documented (13–16).
During early infection, T. brucei stimulates both IFN- and TNF
production, which along with a VSG-specific B cell response re-
sults in the control of parasitemia and overall host resistance (17–
20). In terms of T. brucei Ags responsible for eliciting an initial
macrophage inflammatory response, trypanosomal VSG was
found to encompass two distinct macrophage-activating compo-
nents (21). Although both soluble VSG (sVSG) and membrane-
bound VSG (mfVSG) were shown to have similar TNF-inducing
capacities, the dimyristoylglycerol moiety of the mfVSG anchor
was not required for TNF triggering. This being the case, macro-
phages require IFN- prestimulation before becoming responsive
toward sVSG, whereas the TNF-inducing capacity of mfVSG is
IFN- independent. In an in vivo setting, the absence of either
IFN- or TNF was associated with a severely diminished capacity
to control proliferation of the parasite (19, 20, 22), emphasizing the
importance of these proinflammatory cytokines in the initial con-
trol of the disease.
The importance of MyD88-dependent signaling in other para-
sitic infections indicated that the induction of inflammatory cyto-
kines following a T. brucei infection might be mediated by the
MyD88-dependent activation of an innate immune response. In the
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present study, T. brucei-derived sVSG and mfVSG were found to
activate macrophages in a MyD88-dependent manner. Mice defi-
cient in MyD88 were unable to control both clonal and nonclonal
T. brucei infections. Parasitemia control following clearance of the
first peak of parasites was found to be partly mediated by TLR9,
and macrophages deficient in this TLR were less responsive to-
ward T. brucei genomic DNA than wild-type controls. Therefore,
the data presented here implicates TLR triggering as a critical step
in the initiation of innate immunity against T. brucei.
Materials and Methods
Mice
Mouse strains used in this study include animals deficient in TLR1 (23),
TLR2 (24), TLR2/4 (25), TLR9 (26), MyD88 (27), CD14 (28), TNF (29),
IFN-R1 (30), IL-1R1 (31), and caspase-1 (32). Mice deficient in TLR1,
TLR2, TLR9, MyD88, TNF, IFN-R1, IL-1R1, and caspase-1 were back-
crossed onto a C57BL/6 background five times or more. Mice deficient in
TLR2/4 and CD14 were on 129/SvJ  C57BL/6 and CBA/J backgrounds,
respectively. Age-matched control littermate mice of the corresponding
genetic background were used in all experiments. Mice were obtained from
either the University of Cape Town or the Transgenose Institute animal
breeding facility. All experiments performed were in accordance with the
guidelines of the Animal Research Ethics Board of the University of Cape
Town, South Africa, and the Regional Ethics Committee for Animal Ex-
periments of Toulouse, France.
Parasites and experimental infection
For clonal infections, the Antat1.1E clone of the EATRO 1125 stock of the
pleomorphic bloodstream form was originally provided by Dr. N. Van
Meirvenne (Institute of Tropical Medicine, Antwerp, Belgium). Frozen sta-
bilate stocks of AnTat1.1 T. brucei used for infections were stored at
80°C at the Free University of Brussels. Mice were infected i.p. with 5
103 parasites diluted in PBS (pH 8.0) supplemented with 1.6% glucose.
Animals were bled from the tail at intervals of either 1 or 2 days for the
duration of the infection, and parasites were counted using a light
microscope.
For infections of tsetse flies, male flies from the Glossina morsitans
morsitans colony maintained at the Institute of Tropical Medicine were
used throughout the study. This colony was maintained on rabbits at 25°C
and 65% relative humidity and is characterized by a high intrinsic vectorial
capacity. Teneral flies (8–32 h after emergence) were fed their first blood-
meal on immune-suppressed Naval Medical Research Institute mice (80
mg/kg cyclophosphamide (Endoxan)), showing a parasitemia of 108.4 to
108.7 parasites/ml of a pleiomorphic T. brucei brucei AnTAR1 population,
containing at least 70% short stumpy forms. After the infective meal, flies
were maintained on uninfected rabbits for 28 days, with 3 days/week feed-
ing regime. Twenty-eight days after the infective bloodmeal, flies were
starved for 72 h and were forced to salivate on a prewarmed (37°C) glass
slide. This drop of saliva was examined for the presence of metacyclic
trypanosomes. Metacyclic-infected tsetse flies were retained for the non-
clonal infection experiments.
sVSG, mfVSG, and genomic DNA preparation
Trypanosomes were harvested from infected blood by DE52 chromatog-
raphy (33), using sterile PBS (pH 8.0) supplemented with 1.6% glucose for
equilibration and elution. After separation, parasites were washed and re-
suspended in RPMI 1640 medium at a concentration of 109 parasites/ml.
sVSG was prepared from DE52-purified parasites by osmotic lysis for 5
min at 37°C in 10 mM sodium phosphate (pH 8.0) containing 0.1 mM
N-p-tosyl-L-lysin chloromethyl ketone and 0.1 mM PMSF (Boehringer
Mannheim). The supernatant was passed through a column of DE52 equil-
ibrated in 10 mM sodium phosphate (pH 8.0). sVSG was further purified
on a column of Sephacryl-S200 (Pharmacia Biotech), dialyzed against wa-
ter overnight at 4°C, and freeze dried. mfVSG was prepared according to
the method described previously (34). VSG samples were incubated under
gentle shaking for 2 h at room temperature with Prosep-Remtox (Biopro-
cessing) glass beads to remove possible LPS contamination. Following
this, beads were separated by sample filtration over a 22-m sterile Spin-X
centrifuge tube filter (Costar). Protein concentration of VSG was estimated
by a detergent-compatible protein assay kit (Bio-Rad) using BSA as a
standard. sVSG was resuspended in PBS (pH 8.0), and mfVSG was resus-
pended in PBS containing 0.02% N-octylglucoside (Sigma-Aldrich). For
isolation of T. brucei DNA, DE52-purified parasites were lysed using
TRIzol (Invitrogen Life Technologies), and DNA was purified according to
the manufacturer’s recommendations. DNA was resuspended in water, and
concentrations were determined by spectrophotometric analysis. Endotoxin
units  0.5 pg/mg VSG or DNA were determined using the Limulus ame-
bocyte lysate test (BioWhittaker). VSG preparations contained no T.
brucei DNA.
Primary macrophage cultures
MyD88/ (27), TLR9/ (26), and control murine bone marrow cells
were isolated from femurs and cultivated (106/ml) for 7 days in DMEM
supplemented with 2 mM L-glutamine, 0.2 M 2-ME, 20% horse serum,
and 30% L929 cell-conditioned medium. Following this, cells were resus-
pended in cold PBS and recultured for 3 days in fresh medium at 37°C and
5% CO2.
MyD88/ bone marrow-derived macrophages were plated in 96-well
microculture plates at a density of 105 cells/well. Culture medium used was
DMEM containing 100 U/ml penicillin, 100 g/ml streptomycin, 0.2 M
2-ME, and 2 mM L-glutamine. Cells were stimulated with 1 g/ml LPS
(Escherichia coli, serotype O111:B4; Sigma-Aldrich), 5 or 10 g/ml
sVSG, and 5 or 10 g/ml mfVSG both in the presence or absence of 30
U/ml IFN-. Similarly, TLR9/ bone marrow-derived macrophages were
cultured with 1 g/ml LPS or 1.0 mg/ml, 2.5 g/ml, or 12.5 mg/ml T.
brucei DNA in the presence of 30 U/ml IFN-. All cells were stimulated
for 24 in the presence of 50 U/ml polymyxin B sulfate, following which
supernatants were harvested and frozen at 80°C.
Cytokine measurements
Cytokine content in supernatants and plasma were assayed using commer-
cially available ELISA reagents for TNF-, IL-12p40, and IL-6 (Duoset
R&D Systems).
Quantification of anti-VSG serum titers
Infection-induced anti-VSG serum titers were determined in a VSG solid
phase ELISA. ELISA plates (Nalge Nunc International) were coated in
PBS (pH 8.0) with purified sVSG (10 g/ml to 100 l/well) by overnight
incubation at 4°C. Free binding sites were blocked by an additional over-
coat of BSA (1 mg/ml to 300 l/well, 1 h incubation at 37°C). Serial serum
dilutions were added to the plates and incubated overnight, following
which plates were extensively washed with PBS. Detection of bound serum
Abs was done using 1/1000 dilutions of IgM, and IgG isotype-specific
HRP-coupled Abs (Southern Biotechnology Associates), followed by tet-
ramethylbenzidine substrate addition. After 20 min, the substrate conver-
sion reaction was stopped by addition of 50 l of 1 N H2SO4, and ODs
were measured at 450 nm.
Nitrite measurements
Nitrite concentrations in cell supernatants were determined using the
Griess reaction (3% phosphoric acid, 1% p-aminobenzenesulfonamide, and
1% N-(1-napthyl)ethylenediamide) as described previously (25).
Statistical analysis
The statistical significance of differences in data means was analyzed using
an unpaired Student’s t test. Values of p  0.05 were considered
significant.
Results
Macrophages require MyD88 to respond optimally to sVSG and
mfVSG
It has been shown previously that the glycosyl-inositol-phosphate
moiety of sVSG is the main trypanosome-derived, TNF-inducing
component (21). However, the TNF-inducing capacity of sVSG
required IFN- priming, suggesting that in an in vivo setting, mac-
rophage responsiveness toward sVSG occurs after an IFN- pre-
stimulation event. In the present study, all sVSG macrophage stim-
ulation experiments were performed using a concentration of
protein no higher than 10 g/ml, a dose corresponding to a try-
panosome load of 2  107 parasites during infection. To deter-
mine whether macrophage TNF responses toward sVSG might be
mediated by TLRs, bone marrow-derived macrophages deficient in
the adaptor molecule MyD88 were stimulated with sVSG either in
the presence or absence of IFN- (Fig. 1a). Neither wild-type nor
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MyD88-deficient macrophages responded to sVSG in the absence
of IFN-. Upon prestimulation with IFN-, wild-type macro-
phages produced TNF in a dose-dependent manner, whereas mac-
rophages deficient in MyD88 produced none. TNF production in
response to LPS was reduced in MyD88-deficient macrophages
(Fig. 1a) but not absent. sVSG fractions were free of endotoxin,
indicating that TNF production was solely due to sVSG stimula-
tion. The production of nitrite by wild-type macrophages in re-
sponse to sVSG was dependent on IFN- priming but was reduced
in MyD88-deficient macrophages (Fig. 1b). In contrast to TNF and
nitrite, no IL-6 or IL-12p40 was detected in culture supernatants
(Fig. 1, c and d), and prestimulation with IFN- did not induce
macrophages to secrete IL-6 or IL-12p40 in response to sVSG. In
general, macrophages were far less responsive toward sVSG than
they were to LPS (Fig. 1, a–d). In the present study, cytokine
production induced by 1 g/ml LPS far exceeded that produced by
10 g/ml sVSG.
In response to environmental stress, trypanosomes release their
VSG via a VSG lipase (35). In doing so, the dimyristoylglycerol
VSG anchor remains in the trypanosomal membrane while the
FIGURE 1. Impaired responses to T. brucei Ags in MyD88/ macrophages. a–d, Bone marrow-derived macrophages from wild-type (f) or
MyD88/ () mice were stimulated with LPS (1 g/ml) or AnTat1.1 T. brucei sVSG (5 or 10 g/ml) in the presence or absence of 30 U/ml IFN- for
24 h. TNF, nitrite, IL-6, and IL-12p40 in culture supernatants were determined by ELISA. e–h, Bone marrow-derived macrophages from wild-type and
MyD88/ mice were stimulated with LPS (1 g/ml) or AnTat1.1 T. brucei membrane fraction VSG (5 or 10 g/ml) in the presence or absence of 30
U/ml IFN- for 24 h. Concentrations of TNF, nitrite, IL-6, and IL-12p40 in culture supernatants were determined by ELISA. Each bar represents the average
of four wells, and all experiments were repeated twice. n.d., not detected.
2503The Journal of Immunology
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glycosyl-inositol-phosphate-VSG is released (36). However, dur-
ing a trypanosomal infection, it is also likely that macrophages are
exposed to the VSG-GPI anchor due to lyses of trypanosomes.
Within this context, it has already been shown that mfVSG can
elicit a macrophage response and that this response is independent
of IFN- prestimulation (21). To determine whether mfVSG-in-
duced macrophage responsiveness was dependent on MyD88 sig-
naling, macrophages deficient in MyD88 were stimulated with
mfVSG either in the absence or presence of IFN- (Fig. 1, e–h).
First, macrophages required MyD88 to produce TNF in response
to mfVSG stimulation (Fig. 1e), but in contrast to sVSG, this re-
sponse was not dependent on prestimulation with IFN-. Second,
macrophages did require MyD88 and IFN- prestimulation to pro-
duce nitrite upon mfVSG stimulation (Fig. 1f). Third, unlike mac-
rophages stimulated with sVSG (Fig. 1, c and d), macrophages
stimulated with mfVSG secreted both IL-6 and IL-12p40 (Fig. 1,
g and h), the production of which was not dependent on IFN-
prestimulation. However, while MyD88 was required by macro-
phages to produce IL-6 in response to mfVSG stimulation (Fig.
1g), the production of IL-12p40 was MyD88 independent (Fig.
1h). Therefore, macrophages in general were far more responsive
toward mfVSG than sVSG, and the response required MyD88 for
the production of TNF, IL-6, and nitrite but not IL-12p40.
Mice require MyD88 signaling to control a T. brucei infection
To evaluate the role of MyD88 in host resistance to T. brucei, mice
deficient in MyD88 were infected with pleiomorphic AnTat1.1 T.
brucei. The development of parasitemia and survival of these an-
imals were compared with wild-type controls, as well as mice de-
ficient in either IFN-R1 or TNF (Fig. 2). In terms of development
of parasitemia, mice deficient in MyD88 could not efficiently con-
trol the height of first peak parasitemia, a phenotype similar to
mice deficient in either IFN-R1 or TNF (Fig. 2, a and c). Fol-
lowing clearance of the first peak of parasitemia, wild-type animals
developed a reduced second peak of parasitemia at days 13–15
postinfection and succumbed to the final lethal peak of parasitemia
at40–50 days postinfection (Fig. 2a). Animals deficient in either
MyD88 or IFN-R1 had significantly elevated parasitemia levels
after first peak (Fig. 2a), which remained elevated for the duration
of the infection with both gene-deficient animals succumbing to
infection before wild-type controls ( p  0.01 and p  0.001,
respectively; Fig. 2b). Mice deficient in TNF controlled para-
sitemia development after first peak more effectively than either
MyD88- or IFN-R1-deficient animals (Fig. 2c) and displayed
similar survival kinetics when compared with wild-type controls
( p 0.10; Fig. 2d). Thus, MyD88-deficient animals succumbed to
the infection before TNF-deficient animals ( p 0.01). In addition,
IL-12p40 did not contribute significantly to first-peak parasitemia
control as animals deficient in this cytokine controlled the first
peak of parasitemia as well as wild-type controls (Table I). How-
ever, parasitemia levels did increase slightly in the absence of IL-
12p40 following clearance of the second peak of infection (data
not shown; F. Brombacher, unpublished observation). To deter-
mine whether the impaired resistance of MyD88-deficient mice
toward a T. brucei infection could be attributed to a reduced type
1 immune response, IFN- and TNF were measured in the plasma
at various time points postinfection (Fig. 3, a and b). At 4 days
postinfection, MyD88-deficient mice had reduced plasma IFN-
levels when compared with wild-type controls (Fig. 3a), which
then increased marginally at day 6 postinfection. A similar trend was
observed for plasma TNF levels in MyD88-deficient mice (Fig. 3b).
For comparative purposes, plasma IFN- levels were analyzed in
TNF-deficient animals. In the present study, plasma IFN- levels
were also reduced in mice lacking TNF at days 4 and 6 postinfection
(Fig. 3a). Furthermore, parasite clearance is also mediated by a VSG-
specific Ab response. In the present study, VSG-specific IgM and
FIGURE 2. MyD88 is required to
control a pleomorphic T. brucei An-
Tat1.1 infection. Parasitemia de-
velopment and survival in (a and b)
wild-type (f), MyD88/ (), and
IFN-R1/ (E) and (c and d) wild-
type (f), MyD88/ (), and
TNF/ (E) mice. Five mice per
group were infected at day 0 i.p. with
5  103 AnTat1.1 T. brucei parasites.
Parasitemia data indicate mean  of
five mice per group from one of three
independent experiments, while sur-
vival data are representative of two to
three pooled experiments.
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IgG2a titers at days 4, 6, and 20 postinfection were moderately re-
duced in MyD88-deficient animals (Fig. 3, d–f). Ab titers for IgG1,
IgG2b, and IgG3 in MyD88- and TNF-deficient mice were compa-
rable to wild-type controls for the duration of infection (data not
shown). Thus, the development of a type 1 cytokine and VSG-specific
IgG2a response during a clonal T. brucei infection is mediated in part
by the MyD88-dependent activation of the innate immune system.
Analyses of several TLR-deficient mice reveal a role for TLR9 in
T. brucei parasitemia control
MyD88 is an integral component of the TLR-signaling pathway
(37), but this adaptor molecule is also an important component of
the IL-1 and IL-18-signaling cascade (38–40). In the present
study, animals deficient in MyD88 have been reported to have
reduced responsiveness toward either IL-1 and/or IL-18 (41). To
determine whether the increased susceptibility of MyD88-deficient
animals during a clonal T. brucei infection was associated with
defective IL-1 and/or IL-18 signaling, mice deficient in IL-1R1
and caspase-1 were infected with clonal T. brucei. In contrast to
MyD88-deficient mice, these mice controlled the first and second
peaks of parasitemia as well as wild-type controls (Table I), indi-
cating that the increased susceptibility toward T. brucei observed
for MyD88-deficient animals was due to defective TLR signaling.
Screening of several TLR-deficient animals revealed that neither
TLR1, TLR2, the combination of both TLR2 and TLR4, or TLR9
were required by the host to control the first peak of parasitemia
following a clonal T. brucei infection (Table I). Interestingly, an-
imals deficient in TLR9 developed elevated levels of parasitemia
following clearance of the first peak of parasites (Table I), indi-
cating that TLR9 could be involved in parasitemia control after
first peak.
T. brucei DNA stimulates macrophages in a TLR9-dependent
manner
Following the first wave of parasitemia, lysis of the parasite results
in the release of several parasite components into the bloodstream.
Apart from sVSG and mfVSG that promote a macrophage re-
sponse, it has been reported that DNA from T. brucei is not only
mitogenic for B lymphocytes (42) but induces macrophages to
produce TNF, NO, and IL-12p40 in the presence of IFN-. In the
present study, the extent of B cell proliferation and macrophage
activation was associated with CG dinucleotide content, a feature
associated with bacterial DNA and TLR9 responsiveness (26).
Therefore, it was postulated that induction of an inflammatory re-
sponse following a T. brucei infection might be mediated, in part,
by TLR9-dependent macrophage activation. Indeed, when stimu-
lated with T. brucei DNA, macrophages deficient in TLR9 pro-
duced less TNF (Fig. 4a), IL-6 (Fig. 4b), IL-12p40 (Fig. 4c), and
nitrite (Fig. 4d) than their wild-type counterparts. Macrophages
FIGURE 3. MyD88 is required to
mount an early inflammatory re-
sponse following a T. brucei infec-
tion. a and b, Wild-type (f),
MyD88/ (), and TNF/ (z)
were infected i.p. with 5  103 An-
Tat1.1 T. brucei parasites. Sera was
collected at days 4 and 6 postinfection
and analysed for IFN- and TNF by
ELISA. Results from one of two ex-
periments performed are the mean of
sera samples from three mice. n.d.,
not detected. c–e, Sera was collected
from wild-type (f), MyD88/ (),
and TNF/ (E) mice at days 4, 6,
and 20 postinfection and analyzed for
VSG-specific IgM and IgG2a Abs.
Results are means of sera samples
from three mice from one of two sim-
ilar experiments performed.
Table I. Systemic responses of PRR- and cytokine-deficient mice
following a clonal T. brucei infectiona
Mouse Strain
First Peak Parasitemia
(2.106 par./ml)
Second Peak Parasitemia
(2.106 par./ml)
C57BL/6b 56  7 9  5
TLR1/ 58  6 10  7
TLR2/ 37  4 12  9
TLR9/ 51  14 25  4
MyD88/ 167  47 38  14
TNF/ 197  41 15  13
IFN-R1/ 141  38 111  83
IL-1R1/ 43  10 14 8
Caspase-1/ 55  20 7 2
IL-12p40/ 53  9 16  4
TLR2/4/c 135  48 10  5
TLR2/4/ 121  23 5 4
CBA/Jd 66  31 15  10
CD14/ 58  18 8 5
a Five wild-type and PPR/cytokine-deficient mice were infected i.p. with 5  103
AnTat1.1 T. brucei parasites. Results are representative of two to three similar ex-
periments. par., parasitemia; bold, wild-type parasitemia counts; bold, gene deficient
mice with elevated parasitemia counts. The corresponding numbers have been un-
derlined accordingly.
b Gene-deficient mice backcrossed onto a C57BL/6 background five times
or more.
c Gene-deficient mice on a 129/SvJ  C57BI/6 background.
d Gene-deficient mice on a CBA/J background.
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FIGURE 5. Reduced resistance of TLR9/ mice following an T. brucei infection. a and b, Parasitemia development and survival in wild-type (f) and
TLR9/ () mice infected i.p. with 5  103 AnTat1.1 T. brucei parasites. Results from one of three similar experiments are shown. c–e, Sera was
collected at days 13 and 16 postinfection and analyzed for IFN- and VSG-specific IgG2a Abs by ELISA. Results are means of sera samples from three
mice from one of two similar experiments performed. n.d., not detected.
FIGURE 4. Impaired responses to AnTat1.1 T. bru-
cei genomic DNA in TLR9/ macrophages. a–d,
Bone marrow-derived macrophages from wild-type or
TLR9/ mice were stimulated with CpG ODN (1.0
M), LPS (1.0 g/ml), or the indicated concentrations
of T. brucei genomic DNA in the presence of 30 U/ml
IFN- for 24 h. Concentrations TNF, IL-6, IL-12p40,
and nitrite in culture supernatants were determined by
ELISA. Each bar represents the average of four wells,
and all experiments were repeated twice. n.d., not
detected.
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deficient in TLR9 were unresponsive toward CpG DNA (Fig. 4)
but responded normally to stimulation with LPS. In general, mac-
rophages were far less responsive toward T. brucei genomic DNA
than they were to CpG DNA (Fig. 4), possibly because the fre-
quency of CG dinucleotides in T. brucei genomic DNA is only
3.9% (42). These results suggest that macrophage responsiveness
toward T. brucei DNA is mediated in part by TLR9.
Mice require TLR9 to control parasitemia development
following first peak clearance
Not only did macrophages deficient in TLR9 respond poorly to T.
brucei genomic DNA, but animals deficient in TLR9 infected with
clonal T. brucei had increased numbers of parasites following
clearance of the first peak of parasitemia (Fig. 5a), but no signif-
icant difference was observed in the mean survival time of both
wild-type and TLR9-deficient animals ( p  0.10; Fig. 5b). IFN-
is a critical factor in contributing to parasitemia control following
first peak clearance (Table I; Fig. 2a). Analysis of plasma IFN-
levels in TLR9-deficient mice showed reduced IFN- levels during
the second parasitemia peak (Fig. 5c). Reduced plasma IFN- lev-
els coincided with clearance of the first peak of parasitemia at days
10–13 at a point where 108 parasites would release genomic DNA
into circulation. This was accompanied by lower VSG-specific
IgG2a Ab titers at day 13 postinfection (Fig. 5d), which were re-
stored to wild-type levels by day 16 postinfection (Fig. 5e).
Mice require MyD88 and TLR9 to control a nonclonal T. brucei
infection
In the field, T. brucei parasites that infect livestock initially express
metacyclic VSG and not the clonal form of VSG first seen by the
immune response as present on AnTat1.1 T. brucei parasites (16,
43, 44). Seeing that the murine host required both TLR9 and
MyD88 to control a clonal T. brucei infection, we sought to de-
termine whether this was also true for a nonclonal metacyclic T.
brucei infection. Using a tsetse fly as a vector, mice deficient in
either TLR9 or MyD88 were infected with metacyclic AnTar1.1 T.
brucei parasites (Fig. 6a). When compared with the clonal An-
Tat1.1 T. brucei infection (Figs. 2a and 5a), the nonclonal An-
Tar1.1 T. brucei infection resulted in similar parasitemia profiles
(Fig. 6a). Mice deficient in MyD88 were unable to control both
first and second parasitemia peaks. In the present study, nonclonal
parasitemia levels in MyD88-deficient animals reached 4  108
parasites/ml blood at day 20 postinfection (Fig. 6a), apposed to
2  108 parasites/ml blood for the clonal infection (Fig. 2a). Ad-
ditionally, all MyD88-deficient animals succumbed to nonclonal
infection by day 20 postinfection (Fig. 6b), while these animals
survived for 40 days following a clonal infection (Fig. 2b). Mice
deficient in TLR9 controlled the first peak of parasitemia, as well
as wild-type controls, but were unable to effectively clear parasites
following first peak parasitemia (Fig. 6a). As was seen for
MyD88-deficient mice, TLR9-deficient mice succumbed to the in-
fection before their wild-type controls ( p  0.002 and p  0.005,
respectively; Fig. 6b). These results suggest that in a nonclonal T.
brucei infection both TLR9 and MyD88 are important components
of an innate immune response and are required by the host to
control parasite replication.
Discussion
There is a growing body of evidence that indicates that recognition
of several parasitic infections leads to the MyD88-dependent ac-
tivation of an innate immune response (7–12). In models analyzing
experimental T. gondii, T. cruzi, P. berghei, L. major, or B. burg-
dorferi infections, a deficiency in MyD88 was correlated with re-
duced plasma IL-12p40 and/or IFN- levels during the infection.
This was accompanied by decreased production of IL-12p40 and
IFN- following splenocyte restimulations with parasitic Ags (7,
9, 10, 12). Thus, in these models, the activation of the MyD88-
signaling pathway results in the early production of IFN- and
IL-12, both of which are essential components in host resistance
against parasitic infections.
The cytokines TNF and IFN- have been shown to be critical
factors in determining the relative level of host resistance against
the extracellular parasite T. brucei (19, 20, 22). Deficiencies in
either of these cytokines have been associated with elevated levels
of parasitemia and, in terms of IFN-, shorter survival times. Re-
sults presented here link the initial production of TNF and IFN-
following a T. brucei infection to the MyD88-dependent activation
of an innate immune response. The production of TNF by macro-
phages in response to either sVSG or mfVSG requires signaling
via MyD88. Thus, the release of parasite Ags in the time period
preceding the first peak of parasitemia stimulates macrophages to
produce TNF, which in turn contributes to controlling the height of
first-peak parasitemia. Lower systemic TNF levels present in mice
lacking MyD88 is indicative of a failure by the host to respond to
parasite Ags. However, the activation state of macrophages during
infection may influence the ability of the host to respond to a
Trypanosome infection (45). Indeed, macrophage responsiveness
toward T. brucei sVSG required IFN- prestimulation, which sug-
gests that direct sensitization of host T cells by T. brucei to pro-
duce IFN- (46) occurs before macrophages are fully responsive to
sVSG. However, IL-12p40-mediated activation of the host T cell
compartment does not appear to play a crucial role during a T.
brucei infection as mice deficient in this cytokine control first-peak
parasitemia as well as wild-type controls (Table I; F. Brombacher,
unpublished observation). In addition, stimulation of macrophages
FIGURE 6. Differential require-
ment for MyD88 and TLR9 in con-
trolling a nonclonal T. brucei infec-
tion. a and b, Parasitemia
development and survival of wild-
type (f), MyD88/ (), and
TLR9/ (E) mice. Five mice per
group were infected with metacyclic
AnTar1.1 T. brucei brucei parasites
using Glossina species. as a vector.
Results are expressed as means 
SDs.
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with mfVSG did induce the production of IL-12p40, but this re-
sponse was independent of MyD88 signaling. These results sug-
gest that the induction of an IFN- environment following a T.
brucei infection is independent of the action of IL-12, as previ-
ously shown in experimental infection models using T. cruzi (47),
Listeria monocytogenes (48), and Mycobacterium tuberculosis
(49), but that the induction of IFN- requires signaling via
MyD88. This initial IFN- environment not only controls first
peak parasitemia but also modulates VSG-specific IgM to IgG2a
switching (15), thereby contributing to parasitemia control post
first-peak.
Within this context, MyD88 is required for responsiveness to-
ward IL-1, IL-1, as well as IL-18 (38–41). Deficiencies in these
cytokines have been associated with a diminished capacity to clear
intracellular pathogens and fungi (50–52), with reports attributing
a reduced early protective response to decreased levels of IFN-.
Mice deficient in IL-1R1 and caspase-1 were used to control for
possible decreased responsiveness toward IL-1, IL-1, and IL-
18, respectively. The protease caspase-1 is required for processing
of IL-1 and IL-18 into their biologically active forms (53). In-
fection of mice deficient in either IL-1R1 or caspase-1 showed
little or no differences in terms of parasitemia control when com-
pared with wild-type animals (Table I), and although a role for
MyD88 in IL-1 and IL-18 signaling during infection cannot be
excluded, the necessity for these cytokines appear to be minimal
when compared with TNF and IFN-. Therefore, we attribute the
reduced early protective response observed in MyD88-deficient
animals to defective Toll signaling. However, deficiencies in sev-
eral individual TLRs failed to reproduce the elevated parasitemia
levels observed during first-peak parasitemia in MyD88-deficient
animals (Table I). This would indicate that the control of para-
sitemia is not dependent on activation of an innate immune re-
sponse via TLRs 1, 2, or 4. Although it is possible that these
receptors function cooperatively with one another in response to-
ward parasite components such as sVSG and mfVSG, this study
shows no individual role in vivo either before or after the first peak
of parasitemia. However, a partial role for TLR9 was found to
contribute to parasitemia control following first peak clearance.
During this stage of infection, lyses of 108 parasites would release
more nuclear material into circulation when compared with lyses
of parasites before the first peak of infection. In the present study,
IL-12p40 produced by macrophages in response to T. brucei DNA
could, in turn, induce IFN- production by PBMCs (42) and could
account for the reduced systemic IFN- levels found in TLR9-
deficient mice following clearance of the first peak of parasitemia.
In addition to activating macrophages via TLR9, parasite DNA
may also be involved in triggering B cells to proliferate and dif-
ferentiate (42, 54), thereby contributing to the differentiation of
Th1 cells and isotype switching. Therefore, both sVSG and para-
sitic DNA released systemically during infection contribute to
macrophage activation and the resulting inflammatory response.
The extent to which they contribute to macrophage activation and
the inflammatory response could be more substantially addressed
once a receptor for sVSG has been identified. This being said,
attempts to identify individual TLRs involved in the activation of
a protective innate immune response against other parasitic infec-
tions have been inconclusive. In some cases, purified parasitic
components such as T. cruzi-derived GPI anchor were shown to
activate TLR2 from both mouse and human origin in vitro (55),
although within an in vivo setting, mice deficient in this TLR do
not display a severely reduced capacity to control a T. cruzi in-
fection compared with mice deficient in MyD88 (7). Furthermore,
in murine infection models using P. berghei, T. gondii, and L.
major, investigators have been unable to formally demonstrate that
individual, or combinations of TLRs, are involved in innate rec-
ognition of the aforementioned parasites.
It is likely that the induction of an innate immune response
following a T. brucei infection is mediated by interaction between
several TLRs that signal via MyD88. Indeed, the requirement for
the MyD88-dependent activation of an innate immune response is
far more pronounced in nonclonal T. brucei infections. In the field,
this would indicate that the VSG repertoire presented by the par-
asite is far greater, emphasizing the requirement for the TLR pro-
tein family in initiating an immune response. However, it is also
plausible that recognition of T. brucei is not solely mediated by the
TLR family but could include PRRs involved in recognizing sugar
moieties within the variant surface glycoprotein. An example of
this type of complex formation between the TLR protein family
and proteins unrelated to the TLR family exists for recognition of
endotoxin by the CD14-TLR4-MD2 complex (56, 57). In the case
of T. gondii, parasite-induced IL-12 production by dendritic cells
was found to be mediated by the dual interaction between MyD88
and the CCR5 (12, 58), indicating that TLRs function in concert
with additional cell surface receptors to effect the appropriate im-
mune response. Analysis of the VSG coat covering T. brucei re-
vealed that the galactose side chain composition appears to be
important in terms of the TNF-inducing capacity of sVSG (21).
Thus, while the generation of a protective type 1 immune response
following a T. brucei infection is MyD88 dependent, it is likely
that the initial recognition event is mediated by member(s) of the
TLR family functioning cooperatively with a surface protein(s)
involved in galactose recognition.
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